For clinicians who want to start manufacturing CAR T cells, setting up a cell manufacturing process and QC system that can be transferred to GMP-compliant standards is extremely challenging. The development of a viable protocol is time-consuming and expensive, and translating protocols into SOPs is complicated, often resulting in further delays and expenses.
Learn how the Cell Manufacturing Enabling Package (CMEP) can save you time on process development, allowing you to proceed to validation as soon as possible. Designed by experts, and tested through years of experience in the CliniMACS Prodigy® cell manufacturing facility, it has been developed to accelerate your path toward clinical manufacturing. Complementing this, a matching protocol for establishing flow-based QC of CAR T cells using the MACSQuant® Analyzer has also been developed. Join the webinar to learn more about how you can benefit from these new developments.